002923.SZ
Zhuhai Rundu Pharmaceutical Co., Ltd. [002923.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002923.SZ Stock Summary
Top 10 Correlated Stocks
002923.SZ
In the News
002923.SZ Financial details
Company Rating
-
Market Cap
3.47B
Income
119.41M
Revenue
1.33B
Book val./share
-
Cash/share
-
Dividend
0.35
Dividend %
2.99%
Employees
1.89K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
29.38
Forward P/E
-
PEG
-19.01
P/S
2.96
P/B
2.98
P/C
-
P/FCF
51.77
Quick Ratio
0.93
Current Ratio
1.97
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.36
EPS next Y
-
EPS next Q
-
EPS this Y
9.52%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
6.87%
Revenue last 5Y
5.62%
Revenue Q/Q
-2.08%
EPS Q/Q
-112.78%
-
-
-
-
SMA20
-14.41%
SMA50
20.35%
SMA100
21.07%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
10%
ROC
0.08%
Gross Margin
53%
Oper. Margin
11%
Profit Margin
9%
Payout
86%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
6.81-14.442857
52W High
-15.36%
52W Low
+97.5%
RSI
42.77
Rel Volume
2.39
Avg Volume
5.07M
Volume
12.09M
Perf Week
-5.95%
Perf Month
-1.9%
Perf Quarter
27.97%
Perf Half Y
20.67%
-
-
-
-
Beta
0.369
-
-
Volatility
0.45%, 1.95%
Prev Close
1.8%
Price
11.85
Change
3.13%
002923.SZ Financial Performance
002923.SZ Frequently Asked Questions
What is Zhuhai Rundu Pharmaceutical Co., Ltd. stock symbol ?
Zhuhai Rundu Pharmaceutical Co., Ltd. is a CN stock and trading under the symbol 002923.SZ
What is Zhuhai Rundu Pharmaceutical Co., Ltd. stock quote today ?
Zhuhai Rundu Pharmaceutical Co., Ltd. stock price is $11.85 today.
Is Zhuhai Rundu Pharmaceutical Co., Ltd. stock public?
Yes, Zhuhai Rundu Pharmaceutical Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 5.07M
- Market Capitalization 3.47B
- Employee 1.89K
- CEO Mr. Jie Liu
- Headquarters Zhuhai,CN
- IPO Date 2018-01-05
-
Website
https://www.rdpharma.cn 
Zhuhai Rundu Pharmaceutical Co., Ltd., a pharmaceutical company, develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, CNS, and anesthesia areas in China and internationally. It offers APIs, intermediates, FDF, and pellets, as well as formulations in the forms of capsules, tablets, and injections. The company was founded in 1997 and is headquartered in Zhuhai, China.
